Safety Study of Aminolevulinic Acid (ALA) to Improve Visibility of Brain Tumors During Surgery

NCT00961090 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Aminolevulinic Acid

Sponsor

Matthew R Quigley

Collaborators

[object Object]